Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Change in Accured Expenses (2018 - 2025)

Purple Biotech has reported Change in Accured Expenses over the past 5 years, most recently at $1.6 million for Q4 2022.

  • Quarterly Change in Accured Expenses rose 36.53% to $1.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2022, up 236.28% year-over-year, with the annual reading at $205000.0 for FY2025, 108.72% up from the prior year.
  • Change in Accured Expenses was $1.6 million for Q4 2022 at Purple Biotech, up from -$932000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.8 million in Q1 2021 and troughed at -$3.2 million in Q2 2021.
  • The 5-year median for Change in Accured Expenses is -$76000.0 (2021), against an average of $165545.5.
  • Year-over-year, Change in Accured Expenses skyrocketed 229.9% in 2021 and then crashed 1126.32% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at -$171000.0 in 2018, then surged by 187.13% to $149000.0 in 2019, then crashed by 719.46% to -$923000.0 in 2020, then skyrocketed by 229.9% to $1.2 million in 2021, then skyrocketed by 36.53% to $1.6 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Change in Accured Expenses are $1.6 million (Q4 2022), -$932000.0 (Q3 2022), and -$1.3 million (Q2 2022).